|
|
Substance Name: Budesonide [USAN:INN:BAN:JAN]
RN: 51333-22-3
UNII: Q3OKS62Q6X
InChIKey: VOVIALXJUBGFJZ-KWVAZRHASA-N
Note
- A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.
Molecular Formula
- C25-H34-O6
Molecular Weight
- 430.5376
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Adrenal Cortex Hormones
- Anti-Asthmatic Agents
- Anti-Inflammatory
- Anti-Inflammatory Agents
- Antiviral (COVID-19)
- Autonomic Agents
- Bronchodilator Agents
- Drug / Therapeutic Agent
- Glucocorticoids
- Hormone
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Human Data
- Peripheral Nervous System Agents
- Reproductive Effect
- Respiratory System Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Budesonide
- Budesonide [USAN:INN:BAN:JAN]
MeSH Heading
- Budesonide
Synonyms
- (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
- 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
- Bidien
- Budecort Inhaler
- Budeson
- Budesonide
- Budesonido
- Budesonido [INN-Spanish]
- Budesonidum
- Budesonidum [INN-Latin]
- CCRIS 5230
- Cortivent
- EINECS 257-139-7
- Entocort
- Entocort EC
- Fvolir
- HSDB 8279
- Micronyl
- Preferid
- Pulmicort
- Pulmicort Flexhaler
- Pulmicort Respules
- Respules
- Rhinocort
- Rhinocort Allergy
- Rhinocort alpha
- Rhinocort aqua
- S 1320
- Spirocort
- Uceris
- UNII-Q3OKS62Q6X
Systematic Names
- Budesonide
- Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-
- Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-
Registry Numbers
CAS Registry Number
- 51333-22-3
FDA UNII
- Q3OKS62Q6X
System Generated Number
- 0051333223
Structure Descriptors
InChI
InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1InChIKey
VOVIALXJUBGFJZ-KWVAZRHASA-NSmiles
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | subcutaneous | 173mg/kg (173mg/kg) | GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH BLOOD: CHANGES IN SPLEEN GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
man | TCLo | inhalation | 34ug/kg (0.034mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | Australian and New Zealand Journal of Medicine. Vol. 22, Pg. 511, 1992. |
mouse | LD50 | intraperitoneal | 179mg/kg (179mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
mouse | LD50 | intravenous | 124mg/kg (124mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
mouse | LD50 | oral | 4750mg/kg (4750mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
mouse | LD50 | subcutaneous | 53600ug/kg (53.6mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
rat | LD50 | intraperitoneal | 138mg/kg (138mg/kg) | BLOOD: CHANGES IN SPLEEN BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
rat | LD50 | intravenous | 98900ug/kg (98.9mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
rat | LD50 | oral | > 3200mg/kg (3200mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. | |
rat | LD50 | subcutaneous | 58400ug/kg (58.4mg/kg) | BLOOD: CHANGES IN SPLEEN BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 19, Pg. 4377, 1985. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 226 dec | deg C | EXP | |
log P (octanol-water) | 2.180 | (none) | EST | |
Atmospheric OH Rate Constant | 1.28E-10 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.